Back to research

Research paper

Glucocorticoid treatment and adrenal suppression in children: current view and open issues

Pediatric-specific cortisol thresholds for adrenal insufficiency and HPA-axis recovery after exogenous glucocorticoid exposure. Establishes morning cortisol <150 nmol/L as adrenal insufficiency and >=317 nmol/L as recovered. Reviews glucocorticoid-induced adrenal suppression in children and provides interpretive thresholds for AM cortisol, low-dose ACTH stim, and recovery monitoring after steroid taper.

Indexed context

Improda N, et al.

pediatric-endocrinologyhpa-axiscortisoladrenal-insufficiencyglucocorticoidsdiagnostic-thresholds

Markdown path

content/research/papers/2024-improda-gc-induced-adrenal-insufficiency-children.md

Findings

Pediatric-specific cortisol thresholds for adrenal insufficiency and HPA-axis recovery after exogenous glucocorticoid exposure. Establishes morning cortisol <150 nmol/L as adrenal insufficiency and >=317 nmol/L as recovered. Reviews glucocorticoid-induced adrenal suppression in children and provides interpretive thresholds for AM cortisol, low-dose ACTH stim, and recovery monitoring after steroid taper.

Why it may matter for Levi

Directly relevant to interpreting any AM cortisol or stimulated cortisol drawn for Levi after the March 2026 IV methylprednisolone pulse. Provides the specific pediatric thresholds used in the new diagnostic ranks 14 (AM cortisol + ACTH) and 15 (4-point salivary cortisol) and underpins the new treatment rank 15 (conditional stress-dose steroid policy). Without this paper, AM cortisol values would be interpreted against adult thresholds.

Paper text

Glucocorticoid treatment and adrenal suppression in children: current view and open issues

Improda N, Chioma L, Capalbo D, Bizzarri C, Salerno M — J Endocrinol Invest (2024). PMID 39352628 · Open-access PDF (PMC)

Findings summary

Pediatric narrative review of glucocorticoid-induced adrenal insufficiency (GI-AI) covering mechanism, risk stratification, diagnosis, and management:

  • GI-AI is the most frequent cause of adrenal insufficiency in children, often under-recognized and possibly lethal as adrenal crisis.
  • All GC routes (oral, IV, inhaled, topical, intranasal, intra-articular) can suppress the HPA axis; systemic and parenteral routes and compounds with long half-lives (dexamethasone) and high potency pose the highest risk. Methylprednisolone is moderately suppressive.
  • Risk stratification is time × dose dependent; risk rises meaningfully at ≥3-4 weeks of therapy or doses above ~15-25 mg hydrocortisone-equivalent (≈ 3-5 mg methylprednisolone) daily.
  • Diagnosis: morning serum cortisol is first-line; <5 μg/dL (<150 nmol/L) suggests adrenal insufficiency and warrants physiologic replacement and repeat testing. Dynamic testing (ACTH stim, low-dose Synacthen) is used when morning cortisol is equivocal.
  • Management: slow taper; switch to hydrocortisone when approaching replacement dose; stress-dose coverage during acute illness/surgery until HPA axis recovery is confirmed.

Relevance to Levi

Direct and immediately actionable. Levi completed a 3-day IV methylprednisolone pulse in March 2026 (single pulse, short duration). That exposure is short enough that sustained adrenal suppression is unlikely — but unlikely is not the same as ruled out, and the question becomes live again if repeated pulses or a chronic oral prednisolone taper is considered as part of the contingent steroid-sparing-immunomodulation-if-relapse treatment item (content/treatments/treatments.yaml:114-148).

Three concrete transfers to Levi:

  1. Before any second steroid pulse or chronic oral prednisolone is started, baseline morning cortisol and ACTH should be documented to establish a pre-exposure reference. This is a near-zero-cost change to workflow.
  2. Between pulses, morning cortisol assessment per the Improda thresholds (≥317 nmol/L = likely recovered; <144 nmol/L = likely suppressed; intermediate = consider LD-SST) is the evidence-based monitoring strategy in pediatrics.
  3. Stress-dose coverage for intercurrent illness is a durable policy that should live in the treatments workspace, not just in the neurology team's head, if repeated steroid pulses become the plan.

Separately, this paper is the citation source for why a single 3-day pulse is low risk for sustained GI-AI — useful counterweight to overinterpreting a normal cortisol today as evidence against a baseline HPA abnormality.

Provenance